NCT00930332 2024-02-12Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer PainCanadian Cancer Trials GroupPhase 1 Terminated8 enrolled
NCT05251376 2023-01-19Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone TherapyLyndra Inc.Phase 1 Withdrawn
NCT00125294 2017-09-25Sublingual Methadone for the Management of Cancer Breakthrough PainAHS Cancer Control AlbertaPhase 1 Completed10 enrolled